Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on Prognosis
Recruiting
Observational Study
Endometrial Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 64 (estimated)
- Sponsor
- National Institute of Cancerología · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Endometrial cancer (EC) is one of the most common gynecological neoplasms, being the second in incidence and third in mortality in Mexico. Recent studies show that EC molecular classification (Cancer Genome Atlas Research Network, 2013) serves to establish a more accurate prognosis in these patients and regulate therapeutic behavior in a personalized manner. However, there are no studies on EC mol…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Criteria: Inclusion Criteria:
* Clinical diagnosis of endometrioid-type endometrial cancer with samples available
* That the patients have undergone surgery at INCan.
Exclusion Criteria:
* Samples with CEE of non-endometroid type.
* Samples from patients with double primary neoplasm, including ca…
Contacts